Target intelligence / Profile preview

Airway mucoprotein disulfide bonds

Molecular classification
Structural protein feature, Post-translational modification, Other
01

Overview

Airway mucoprotein disulfide bonds are the critical chemical linkages that stabilize the complex, three-dimensional network of gel-forming mucins, primarily MUC5AC and MUC5B, within the respiratory tract (Bonser et al., 2016, JCI Insight). These covalent bonds form between cysteine-rich domains of mucin monomers, facilitating the polymerization required for mucus to exhibit its characteristic viscoelastic properties (Fahy and Dickey, 2010, NEJM). In pathological conditions such as cystic fibrosis and chronic obstructive pulmonary disease (COPD), the density of these disulfide cross-links increases, often exacerbated by oxidative stress, resulting in thick, tenacious mucus that obstructs the airways and impairs mucociliary clearance (Sadowska, 2012, Paediatric Respiratory Reviews). Therapeutic intervention focuses on the use of thiol-containing mucolytic agents, such as N-acetylcysteine, which act as reducing agents to break these disulfide bonds. By converting the bridges into individual sulfhydryl groups, these drugs fragment the large mucin polymers into smaller, less viscous components, thereby improving airway patency and facilitating the clearance of secretions (Yuan et al., 2015, Respiratory Medicine).

Other names
Mucin disulfide bondsMucus disulfide bridgesMucoprotein disulfide linkagesIntermolecular disulfide bonds in mucins
02

Mechanism of action

Reduction of intermolecular disulfide bonds between mucin polymers into free sulfhydryl groups, leading to the depolymerization of the mucus gel and a reduction in its viscosity (Sadowska, 2012, Paediatric Respiratory Reviews).

03

Biological functions

Mucus gel formationViscoelasticity regulationAirway defenseMucociliary clearance
04

Disease associations

Cystic fibrosisChronic obstructive pulmonary disease (COPD)AsthmaBronchiectasisAcute bronchitis
05

Safety considerations

Bronchospasm (especially in asthmatic patients)Airway irritationUnpleasant sulfurous odorPotential inactivation of certain inhaled antibiotics
06

Interacting drugs

N-acetylcysteine

4 more in the full profile.

07

Biomarkers

Sputum viscosityMucociliary clearance (MCC) rateForced expiratory volume in 1 second (FEV1)Sputum rheology

Beyond the preview

Go deeper on Airway mucoprotein disulfide bonds.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Airway mucoprotein disulfide bonds.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call